ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.36695
0.30%
Brent Oil
74.715
0.65%
Bitcoin
96,177.74
0.05%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) Noticias

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TRIB
FechaHoraFuenteTítuloSímboloCompañía
14/02/202515:15Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
06/02/202508:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
06/02/202506:30GlobeNewswire Inc.Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialNASDAQ:TRIBTrinity Biotech PLC
28/01/202506:20GlobeNewswire Inc.Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyNASDAQ:TRIBTrinity Biotech PLC
27/12/202415:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
26/12/202417:19Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:TRIBTrinity Biotech PLC
24/12/202407:33GlobeNewswire Inc.Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanNASDAQ:TRIBTrinity Biotech PLC
18/12/202410:00GlobeNewswire Inc.Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVNASDAQ:TRIBTrinity Biotech PLC
05/12/202415:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
02/12/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
29/11/202415:45Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:TRIBTrinity Biotech PLC
15/11/202416:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
15/11/202408:00GlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
14/11/202416:26Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
07/11/202407:19GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
25/10/202407:45GlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
25/10/202407:45GlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
07/10/202407:15GlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
24/09/202415:05GlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
18/09/202415:05GlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
09/09/202415:05GlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
03/09/202408:55GlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
26/08/202415:05GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesNASDAQ:TRIBTrinity Biotech PLC
20/08/202416:00GlobeNewswire Inc.Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing DirectorNASDAQ:TRIBTrinity Biotech PLC
14/08/202406:30GlobeNewswire Inc.Trinity Biotech Announces Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
13/08/202415:05GlobeNewswire Inc.Trinity Biotech to Announce Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
06/08/202415:05GlobeNewswire Inc.Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
02/08/202408:24GlobeNewswire Inc.Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScienceNASDAQ:TRIBTrinity Biotech PLC
12/07/202415:07Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:TRIBTrinity Biotech PLC
09/07/202415:05GlobeNewswire Inc.Trinity Biotech Announces Appointment of A New CFONASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NYSE
NKE
Nike
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
CCOM
US30
US 30
COIN
DOGEUSD
Dogecoin
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios